Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.005 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
ISIC2021_abstractbook-Alesandrova 2.pdf.jpg2021The effectiveness of ademetionine on the stages of liver fibrosis and the pentraxin-3 levels in patients with non-alcoholic fatty liver disease on the background of arterial hypertensionAleksandrova, Tetiana; Malhotra, Shubham; Suman, Tanu
Rozhdestvenska_Metabolism_0127.pdf.jpg2021-01Non-alcoholic Fatty Liver Disease in Patients with Hypertension: Carbohydrate Metabolism and Liver Parenchyma ConditionRozhdestvenska, Anastasiia; Zhelezniakova, Natalia; Kurinna, Olena
Rozhdestvenska_hkccasc2021.pdf.jpg2021-07Hypertension as an intensification factor of metabolic and inflammatory deviations in patients with non-alcoholic fatty liver diseaseZhelezniakova, Natalia; Rozhdestvenska, Anastasiia
2021-09Diagnostic and Prognostic Potential of Kallistatin in Assessment of Liver Parenchyma Changes in Patients with Non-alcoholic Fatty Liver Disease and HypertensionZhelezniakova, Natalia; Rozhdestvenska, Anastasiia
Rozhdestvenska_Article_Maltepe.pdf.jpg2021-08Diagnostic capabilities of kallistatin, IL-10 and IL-1β in patients with non-alcoholic fatty liver disease and hypertensionZhelezniakova, Natalia; Rozhdestvenska, Anastasiia
Rozhdestvenska EURECA.pdf.jpg2021-09IL-1β and IL-10: diagnostic and prognostic potential of cytokines in the assessment of progression of non-alcoholic fatty liver disease in patients with hypertensionRozhdestvenska, Anastasiia; Zhelezniakova, Natalia
Статья Синайко WoS 2021.pdf.jpg2021Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver diseaseBilovol, O.; Kniazkova, I.; Zemlianitsyna, O.; Dunaieva, I.; Romanova, I.; Kurilo, O.; Sinaiko, V.; Kravchun, N.
Bilovol et al_Hepatic fibrosis as an additional.pdf.jpg2021Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver diseaseBilovol, O.; Kniazkova, I.; Zemlianitsyna, O.; Dunaieva, I.; Romanova, I.; Kurilo, O.; Sinaiko, V.; Kravchun, N.
Dunaieva et al_Adiponektinemia in patients.pdf.jpg2021Adiponektinemia in patients with type 2 diabetes mellitus and var ious stages of non-alcoholic fat liver diseaseDunaieva, I.; Kravchun, N.; Zemlianitsyna, O.
ISIC2021_abstractbook-Alesandrova 1.pdf.jpg2021Clinical significance of pentraxin-3 and C-reactive protein in the differentiation of stages of nonalcoholic fatty liver diseaseAleksandrova, Tetiana; Dhainy, Ali; Isam, Mohamed